Mouse Anti-JMJD4 Recombinant Antibody (A721) (CBMAB-AP4053LY)

Tang, Y., Feng, M., Su, Y., Ma, T., Zhang, H., Wu, H., ... & Xu, D. (2023). Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy. Circulation, 147(22), 1684-1704.

Elsayed, W. S., Harb, O. A., Alabiad, M. A., Saad, R. H. F., Anbaig, A., Alorini, M., ... & Ali, R. M. (2023). Protein Expression of NEK2, JMJD4, and REST in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical, Pathological, and Prognostic Findings. Iranian Journal of Pathology, 18(2), 180.

Li, Z., Zhou, Y., Jia, K., Yang, Y., Zhang, L., Wang, S., ... & Hou, J. (2022). JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesis. Journal of Hematology & Oncology, 15(1), 1-19.

Yan, H., Bao, Y., & Lin, Z. (2021). High Expression of JMJD4 Is a Potential Diagnostic and Prognostic Marker of Renal Cell Carcinoma. Disease Markers, 2021.

Aertker, K. (2021). Studies on recently identified activities of the Jumonji-C oxygenase JMJD4 and the bacterial class D nucleophilic serine β-lactamases (Doctoral dissertation, University of Oxford).

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols